financetom
Business
financetom
/
Business
/
FTC asks to delay Amazon trial due to 'severe resource shortfalls'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FTC asks to delay Amazon trial due to 'severe resource shortfalls'
Mar 12, 2025 9:55 AM

March 12 (Reuters) - The U.S. Federal Trade Commission

asked a federal court in Seattle to delay a September trial in

its case alleging Amazon ( AMZN ) misled consumers over its Prime

subscription service, citing "severe resource shortfalls in

terms of both money and personnel," on Wednesday.

Jonathan Cohen, an attorney for the FTC, told U.S. District

Judge John Chun during a hearing that the agency is facing a

"dire resource situation" amid cost cutting measures enacted

under President Donald Trump's administration.

"We have lost employees in the agency, in our division

and on our case team," Cohen said.

Some employees on the case took a resignation offer

sent out in January

, and others resigned for other reasons, or are scheduled to

be on leave during the trial, and their positions cannot be

filled due to a hiring freeze, Cohen said.

Cohen also cited new spending restrictions limiting FTC

attorneys to purchasing transcripts of court proceedings and

depositions on the slowest delivery schedule, which carries the

cheapest rate but can take weeks to arrive.

The judge asked the FTC to put in writing its request to

delay the trial to later in the fall.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Teva Pharmaceutical third-quarter profit, revenue top estimates
Teva Pharmaceutical third-quarter profit, revenue top estimates
Nov 6, 2024
JERUSALEM, Nov 6 (Reuters) - Teva Pharmaceutical Industries reported a larger than expected rise in third-quarter profit, boosted by strong sales of copycat medicines and its branded drugs to treat migraines and Huntington's disease. The world's largest generic drugmaker said on Wednesday it earned 69 cents per diluted share excluding one-time items in the July-September quarter, up from 60 cents...
ODP's Q3 Adjusted Earnings, Sales Fall
ODP's Q3 Adjusted Earnings, Sales Fall
Nov 6, 2024
07:22 AM EST, 11/06/2024 (MT Newswires) -- ODP (ODP) reported Q3 adjusted earnings from continuing operations Wednesday of $0.71 per diluted share, down from $2.17 a year earlier. Three analysts polled by Capital IQ expected $1.60. Sales for the quarter ended Sept. 30 were $1.78 billion, down from $2.01 billion a year earlier. Three analysts surveyed by Capital IQ expected...
Explainer-How Trump's second administration affects business: Musk, tariffs and more
Explainer-How Trump's second administration affects business: Musk, tariffs and more
Nov 6, 2024
(Reuters) - Donald Trump's return to the White House after winning the Nov. 5 U.S. presidential election may reshape American business. Much depends on whom he appoints as deputies and cabinet members, including the role of Tesla CEO Elon Musk, and what tariffs he enacts. Following are some major issues and sectors to watch: WHAT ROLE WILL ELON MUSK PLAY? After...
Aurora Cannabis Q2 Profit Advances
Aurora Cannabis Q2 Profit Advances
Nov 6, 2024
07:25 AM EST, 11/06/2024 (MT Newswires) -- Aurora Cannabis ( ACB ) on Wednesday said second-quarter profit and revenue rose. Net income from continuing operations climbed to $1.7 million in the second quarter from $0.4 million in the same period last year. Total net revenue climbed 29% to $81.1 million from $63.1 million. The increase was mainly due to a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved